24/120
1.0 / 5 stars
All 120 Win/Lose results shown below
LNSR Roast Me summary
LENSAR, Inc. (LNSR). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseLNSR / S&P -4.19% / 15.20% |
LoseLNSR / S&P 4.61% / 15.00% |
LoseLNSR / S&P LNSR unavailable / 50.40% |
| 2026-Q10/3 |
LoseLNSR / S&P -48.75% / -4.33% |
LoseLNSR / S&P 3.09% / 11.30% |
LoseLNSR / S&P LNSR unavailable / 27.70% |
| 2025-Q41/3 |
LoseLNSR / S&P -5.83% / 2.65% |
WinLNSR / S&P 12.39% / 9.00% |
LoseLNSR / S&P LNSR unavailable / 13.40% |
| 2025-Q31/3 |
LoseLNSR / S&P -6.23% / 8.12% |
WinLNSR / S&P 25.22% / 4.61% |
LoseLNSR / S&P LNSR unavailable / 13.45% |
| 2025-Q21/3 |
LoseLNSR / S&P -6.73% / 10.94% |
WinLNSR / S&P 34.40% / 4.83% |
LoseLNSR / S&P LNSR unavailable / 10.63% |
| 2025-Q12/3 |
WinLNSR / S&P 57.94% / -4.27% |
WinLNSR / S&P 31.44% / 4.98% |
LoseLNSR / S&P LNSR unavailable / 10.57% |
| 2024-Q42/3 |
WinLNSR / S&P 95.20% / 2.41% |
WinLNSR / S&P 28.69% / 5.25% |
LoseLNSR / S&P LNSR unavailable / 6.15% |
| 2024-Q31/3 |
LoseLNSR / S&P 1.78% / 5.89% |
WinLNSR / S&P 23.13% / 5.89% |
LoseLNSR / S&P LNSR unavailable / 6.11% |
| 2024-Q22/3 |
WinLNSR / S&P 32.47% / 4.28% |
WinLNSR / S&P 19.72% / 5.38% |
LoseLNSR / S&P LNSR unavailable / 5.12% |
| 2024-Q11/3 |
LoseLNSR / S&P -3.22% / 10.56% |
WinLNSR / S&P 34.17% / 5.71% |
LoseLNSR / S&P LNSR unavailable / 5.59% |
| 2023-Q42/3 |
WinLNSR / S&P 13.59% / 11.69% |
WinLNSR / S&P 21.31% / 6.81% |
LoseLNSR / S&P LNSR unavailable / 7.78% |
| 2023-Q31/3 |
LoseLNSR / S&P -27.29% / -3.27% |
WinLNSR / S&P 10.40% / 7.52% |
LoseLNSR / S&P LNSR unavailable / -5.03% |
| 2023-Q21/3 |
WinLNSR / S&P 70.68% / 8.74% |
LoseLNSR / S&P 1.53% / 9.50% |
LoseLNSR / S&P LNSR unavailable / -8.57% |
| 2023-Q10/3 |
LoseLNSR / S&P -15.88% / 7.50% |
LoseLNSR / S&P -10.72% / 10.77% |
LoseLNSR / S&P LNSR unavailable / -15.69% |
| 2022-Q40/3 |
LoseLNSR / S&P -46.67% / 7.56% |
LoseLNSR / S&P -0.17% / 11.88% |
LoseLNSR / S&P LNSR unavailable / -17.99% |
| 2022-Q31/3 |
LoseLNSR / S&P -14.75% / -4.88% |
WinLNSR / S&P 13.86% / 13.47% |
LoseLNSR / S&P LNSR unavailable / -1.41% |
| 2022-Q22/3 |
WinLNSR / S&P -12.03% / -16.10% |
WinLNSR / S&P 20.61% / 13.71% |
LoseLNSR / S&P LNSR unavailable / 11.04% |
| 2022-Q12/3 |
WinLNSR / S&P 23.54% / -4.60% |
WinLNSR / S&P 32.46% / 15.97% |
LoseLNSR / S&P LNSR unavailable / 42.23% |
| 2021-Q41/3 |
LoseLNSR / S&P -21.70% / 11.03% |
WinLNSR / S&P 29.46% / 15.00% |
LoseLNSR / S&P LNSR unavailable / 96.40% |
| 2021-Q31/3 |
LoseLNSR / S&P -11.66% / 0.58% |
WinLNSR / S&P 16.81% / 10.77% |
LoseLNSR / S&P LNSR unavailable / 69.42% |
| 2021-Q22/3 |
WinLNSR / S&P 19.28% / 8.55% |
WinLNSR / S&P 8.67% / 6.58% |
LoseLNSR / S&P LNSR unavailable / 51.81% |
| 2021-Q10/3 |
LoseLNSR / S&P 0.14% / 6.17% |
LoseLNSR / S&P LNSR unavailable / -1.06% |
LoseLNSR / S&P LNSR unavailable / 7.39% |
| 2020-Q40/3 |
LoseLNSR / S&P LNSR unavailable / 12.15% |
LoseLNSR / S&P -13.53% / -3.72% |
LoseLNSR / S&P LNSR unavailable / -33.42% |
| 2020-Q30/3 |
LoseLNSR / S&P LNSR unavailable / 8.93% |
LoseLNSR / S&P LNSR unavailable / -2.04% |
LoseLNSR / S&P LNSR unavailable / -27.10% |
| 2020-Q20/3 |
LoseLNSR / S&P LNSR unavailable / 20.54% |
LoseLNSR / S&P LNSR unavailable / -0.46% |
LoseLNSR / S&P LNSR unavailable / -27.11% |
| 2020-Q10/3 |
LoseLNSR / S&P LNSR unavailable / -19.60% |
LoseLNSR / S&P LNSR unavailable / 3.47% |
LoseLNSR / S&P LNSR unavailable / -14.75% |
| 2019-Q40/3 |
LoseLNSR / S&P LNSR unavailable / 9.07% |
LoseLNSR / S&P LNSR unavailable / 5.36% |
LoseLNSR / S&P LNSR unavailable / 2.99% |
| 2019-Q30/3 |
LoseLNSR / S&P LNSR unavailable / 1.70% |
LoseLNSR / S&P LNSR unavailable / 5.02% |
LoseLNSR / S&P LNSR unavailable / 0.21% |
| 2019-Q20/3 |
LoseLNSR / S&P LNSR unavailable / 4.30% |
LoseLNSR / S&P LNSR unavailable / 6.64% |
LoseLNSR / S&P LNSR unavailable / 8.65% |
| 2019-Q10/3 |
LoseLNSR / S&P LNSR unavailable / 13.65% |
LoseLNSR / S&P LNSR unavailable / 8.12% |
LoseLNSR / S&P LNSR unavailable / 14.29% |
| 2018-Q40/3 |
LoseLNSR / S&P LNSR unavailable / -13.52% |
LoseLNSR / S&P LNSR unavailable / 9.05% |
LoseLNSR / S&P LNSR unavailable / 18.23% |
| 2018-Q30/3 |
LoseLNSR / S&P LNSR unavailable / 7.71% |
LoseLNSR / S&P LNSR unavailable / 10.21% |
LoseLNSR / S&P LNSR unavailable / 19.06% |
| 2018-Q20/3 |
LoseLNSR / S&P LNSR unavailable / 3.43% |
LoseLNSR / S&P LNSR unavailable / 9.03% |
LoseLNSR / S&P LNSR unavailable / 14.46% |
| 2018-Q10/3 |
LoseLNSR / S&P LNSR unavailable / -0.76% |
LoseLNSR / S&P LNSR unavailable / 7.68% |
LoseLNSR / S&P LNSR unavailable / 12.46% |
| 2017-Q40/3 |
LoseLNSR / S&P LNSR unavailable / 6.64% |
LoseLNSR / S&P LNSR unavailable / 7.03% |
LoseLNSR / S&P LNSR unavailable / 13.82% |
| 2017-Q30/3 |
LoseLNSR / S&P LNSR unavailable / 4.48% |
LoseLNSR / S&P LNSR unavailable / 5.68% |
LoseLNSR / S&P LNSR unavailable / 17.57% |
| 2017-Q20/3 |
LoseLNSR / S&P LNSR unavailable / 3.09% |
LoseLNSR / S&P LNSR unavailable / 4.83% |
LoseLNSR / S&P LNSR unavailable / 17.74% |
| 2017-Q10/3 |
LoseLNSR / S&P LNSR unavailable / 6.07% |
LoseLNSR / S&P LNSR unavailable / 3.67% |
LoseLNSR / S&P LNSR unavailable / 13.32% |
| 2016-Q40/3 |
LoseLNSR / S&P LNSR unavailable / 3.82% |
LoseLNSR / S&P LNSR unavailable / 2.09% |
LoseLNSR / S&P LNSR unavailable / 7.05% |
| 2016-Q30/3 |
LoseLNSR / S&P LNSR unavailable / 3.85% |
LoseLNSR / S&P LNSR unavailable / 0.20% |
LoseLNSR / S&P LNSR unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | LNSR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -32.82% | 20.78% |
| Annualized return | -32.82% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | LNSR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -4.18% | 83.14% |
| Annualized return | -0.85% | 12.86% |
10Y · 2020-10-02 to 2026-08-28
| Metric | LNSR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -8.33% | 319.30% |
| Annualized return | -0.87% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |